JPMORGAN CHASE & CO - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 206 filers reported holding MYRIAD GENETICS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$2,152,038
-30.5%
134,167
+0.4%
0.00%
Q2 2023$3,098,656
-15.5%
133,678
-15.3%
0.00%
Q1 2023$3,667,000
+179478.8%
157,862
+12.2%
0.00%
Q4 2022$2,042
-99.9%
140,686
-13.2%
0.00%
Q3 2022$3,094,000
-43.1%
162,153
-45.8%
0.00%
-100.0%
Q2 2022$5,435,000
-72.7%
299,053
-62.1%
0.00%
-50.0%
Q1 2022$19,910,000
+1.3%
790,043
+10.9%
0.00%0.0%
Q4 2021$19,664,000
-18.6%
712,491
-4.7%
0.00%
-33.3%
Q3 2021$24,144,000
-0.5%
747,728
-5.7%
0.00%0.0%
Q2 2021$24,259,000
+184.0%
793,332
+182.8%
0.00%
+200.0%
Q1 2021$8,543,000
+18.7%
280,566
-22.9%
0.00%0.0%
Q4 2020$7,200,000
-16.8%
364,123
-46.4%
0.00%0.0%
Q3 2020$8,650,000
+69.5%
679,081
+50.9%
0.00%0.0%
Q2 2020$5,103,000
+9.2%
449,907
+37.8%
0.00%0.0%
Q1 2020$4,674,000
-74.7%
326,602
-51.9%
0.00%
-66.7%
Q4 2019$18,472,000
+29.7%
678,373
+36.3%
0.00%0.0%
Q3 2019$14,247,000
+175.1%
497,621
+157.1%
0.00%
+200.0%
Q2 2019$5,179,000
-23.3%
193,530
-4.8%
0.00%0.0%
Q1 2019$6,751,000
+7.6%
203,352
-5.8%
0.00%0.0%
Q4 2018$6,276,000
-64.2%
215,877
-43.3%
0.00%
-66.7%
Q3 2018$17,515,000
+59.9%
380,775
+29.9%
0.00%
+50.0%
Q2 2018$10,952,000
-3.9%
293,050
-24.0%
0.00%0.0%
Q1 2018$11,398,000
+18.6%
385,720
+37.8%
0.00%0.0%
Q4 2017$9,612,000
-10.6%
279,857
-5.8%
0.00%0.0%
Q3 2017$10,754,000
+101.5%
297,072
+43.8%
0.00%
+100.0%
Q2 2017$5,337,000
+4274.6%
206,529
+3137.6%
0.00%
Q1 2017$122,000
+8.0%
6,379
-5.8%
0.00%
Q4 2016$113,000
-17.5%
6,773
+1.8%
0.00%
Q3 2016$137,000
+117.5%
6,656
+224.4%
0.00%
Q2 2016$63,000
-94.3%
2,052
-93.1%
0.00%
Q1 2016$1,110,000
-12.0%
29,663
+1.6%
0.00%
Q4 2015$1,261,000
+4.3%
29,205
-9.4%
0.00%
Q3 2015$1,209,000
+11.9%
32,244
+1.5%
0.00%
Q2 2015$1,080,000
-18.9%
31,758
-15.6%
0.00%
Q1 2015$1,332,000
+3.9%
37,629
-0.0%
0.00%
Q4 2014$1,282,000
-1.1%
37,644
+12.0%
0.00%
Q3 2014$1,296,000
+165.6%
33,606
+168.3%
0.00%
Q2 2014$488,000
+34.8%
12,524
+18.4%
0.00%
Q1 2014$362,000
-50.6%
10,582
-69.7%
0.00%
Q4 2013$733,000
-48.0%
34,888
-41.8%
0.00%
Q3 2013$1,410,000
-6.0%
59,974
+7.4%
0.00%
Q2 2013$1,500,00055,8370.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$98,875,0003.47%
Tieton Capital Management, LLC 187,636$3,711,0002.72%
Glenview Capital Management 3,682,691$72,825,0001.67%
Altium Capital Management LP 218,650$4,324,0001.61%
S&T BANK/PA 331,098$6,547,0001.18%
EARNEST PARTNERS LLC 6,731,429$133,114,0000.92%
DISCIPLINED GROWTH INVESTORS INC /MN 2,078,075$41,094,0000.79%
SummerHaven Investment Management, LLC 35,700$706,0000.55%
AIMZ Investment Advisors, LLC 42,685$844,0000.44%
CONTINENTAL ADVISORS LLC 36,392$720,0000.33%
View complete list of MYRIAD GENETICS INC shareholders